Trastuzumab deruxtecan vs treatment of physician's choice in patients with HER2-low unresectable and/or metastatic breast cancer: Subgroup analyses from DESTINY-Breast04Nadia Harbeck,Shanu Modi,William Jacot,Toshinari Yamashita, Joo Hyuk Sohn,Maria Vidal,Junji Tsurutani,Naoto T. Ueno,Aleix Prat,Naoki Niikura,Binghe Xu,Hope Rugo,Konstantinos Papazisis,Javier Cortes,Ian Krop,Dhiraj Gambhire, Lotus Yung,Yibin Wang,Jasmeet Singh,David CameronCANCER RESEARCH（2023）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
